Centessa Pharmaceuticals PLC ADR

NASDAQ CNTA

Data sourced from iex and EODHD
Download Data

Centessa Pharmaceuticals PLC ADR Income Statement 2021 - 2024

This table shows the Income Statement for Centessa Pharmaceuticals PLC ADR going from 2021 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Revenue
M 0 7 0 0 0 0 0 0 0 0 0 0 -
Cost of Revenue
M 0 0 0 0 0 0 - - - - - - -
Gross Profit
M 0 7 0 0 0 0 - - - - - - -
Operating Expenses
M 36 42 40 47 49 42 - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 13 12 12 13 16 14 12 15 14 13 12 12 8
Research and Development (R&D) Expenses
M 23 30 28 34 33 28 37 54 37 42 26 18 -
Other Operating Expenses
M 0 0 0 0 0 0 - - - - - - -
Costs and Expenses
M 36 42 40 47 49 42 - - - - - - -
Operating Income
M -36 -35 -40 -47 -49 -42 -49 -68 -53 -58 -38 -41 -239
Interest Expense
M 3 3 3 2 2 2 2 2 1 1 0 0 -
Non-operating Income/Expense
M -1 -1 -2 -2 -1 -2 -5 4 -1 -4 -2 -12 -
EBT
M -38 -36 -41 -49 -50 -44 -54 -65 -54 -61 -40 -41 -239
Income Tax Provision
M 0 1 -3 -24 1 -1 0 0 0 0 0 -11 -
Income after Tax
M -38 -37 -39 -25 -51 -43 -54 -65 -54 -61 -40 -30 -
Non-Controlling Interest
M - - 0 14 -12 0 0 0 0 0 0 0 -
Net Income
M - - -39 -39 -39 -43 -54 -65 -54 -61 -40 -41 -239
Shares (Basic, Weighted)
M - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 99,887,720.00 97,923,585.00 96,648,110.00 95,162,734.00 94,937,904.00 94,603,860.00 94,327,914.00 94,109,089.00 90,505,345.00 89,935,902.00 89,899,454.00 63,516,656.00 85,924,419.00
EBITDA
M -36 -35 -39 -46 -48 -42 -52 -63 -51 -56 -40 -30 -
Depreciation and Amortization
M 0 0 0 0 1 0 -3 5 2 0 -2 11 -
EBIT
M -36 -35 -39 -46 -49 -42 -49 -68 -53 -56 -38 -41 -19
Income from Discontinued Operations
M - - - - - - - - - - - - -
Tax Rate (Effective)
% -1.28 -3.21 6.81 49.15 -1.35 1.51 0.26 0.03 -0.15 -0.19 0.16 27.36 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0
Gross Profit Margin
% - 96.41 - - - - - - - - - - -
Operating Income Margin
% - -513.32 - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - -
EBITDA Ratio
% - -509.73 - - - - - - - - - - -
EBIT Ratio
% - -513.32 - - - - - - - - - - -
EBT Ratio
% - -520.84 - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email